# Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma

> **NCT06302881** · — · UNKNOWN · sponsor: **First Affiliated Hospital of Chongqing Medical University** · enrollment: 207 (actual)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06302881
- **Lead sponsor:** First Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2022-07
- **Final completion:** 2024-03
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06302881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06302881, "Differentiating Tumor-stroma Ratio in Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06302881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*